Page 1 of 3
Loading...
Page 1 of 3
The global narcolepsy drugs market size was valued at $2,680.06 million in 2020, and is projected to reach $6,667.80 million by 2030, registering a CAGR of 9.6% from 2021 to 2030. Narcolepsy ...
The global pneumonia therapeutics market size was valued at $12,293.9 million in 2020, and is projected to reach $25,546.8 million by 2030, registering a CAGR of 8.5% from 2021 to 2030. Pneumonia ...
The global oligonucleotide synthesis market was valued at $5,197.50 million in 2020, and is projected to reach $26,099.90 million by 2030, registering a CAGR of 17.10% from 2021 to 2030.
The erythropoietin drugs market size was valued at $9,243.12 million in 2020, and is projected to reach $14,414.59 million by 2028, registering a CAGR of 5.7% from 2021 to 2028.
Dialysis is a technique used to remove waste products, such as urea and creatinine from the blood due to abnormal functioning of the kidneys and is usually required for people suffering from ...
The global ophthalmic drugs market generated $36,488.48 million in 2019, and is projected to reach $58,134.92 million by 2027, growing at a CAGR of 5.6% from 2020 to 2027. The ophthalmic drugs ...
The global oncology drugs market was valued at $128,352 million in 2019, and is projected to reach $222,380 million by 2027, registering a CAGR of 7.4%.
The global telmisartan market size was valued at $3,453 million in 2019, and is projected to reach $4,258 million by 2027, registering a CAGR of 3.4% from 2020 to 2027.
The Gulf Pain Management Drugs Market size was valued at $851.08 million in 2019, and is projected to reach $1,047.91 million by 2027, registering a CAGR of 3.2%.
The U.S. pain management drugs market size was valued at $31,499.07 million in 2019, and is projected to reach $39,356.45 million by 2027, registering a CAGR of 3.4%.
The global HIV drugs market was valued at $30,891.48 million in 2019, and is expected to reach $36,495.47 million by 2027, registering a CAGR of 3.8% from 2020 to 2027.
The LATAM pain management drugs market was valued at $2,683.82 million in 2019, and is projected to reach $3,383.20 million by 2027, registering a CAGR of 3.5% from 2020 to 2027.
The global rheumatoid arthritis drugs market size was valued at $57,929 million in 2019, and is projected to reach $62,935 million by 2027, registering a CAGR of 2.8% from 2020 to 2027.
The global pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach $91,649.16 million by 2027, registering a CAGR of 3.8% from 2020 to 2027.
The North America liver disease treatment market accounted for $6,970 million in 2019, and is expected to reach $8,318 million by 2027, registering a CAGR of 5.2% from 2020 to 2027.
The global radiodermatitis market size was valued at $477.48 million in 2019, and is projected to reach $609.68 million by 2027, registering a CAGR of 4.1% from 2020 to 2027.
The global anti-viral therapies market size was valued at $38,316.5 million in 2018, and is projected to reach $46,213.4 million by 2026 registering a CAGR of 2.4% from 2019 to 2026.Anti-viral drugs ...
The global osteoporosis drugs market accounted for $7,657 million in 2018, and is expected to reach $10,479 million by 2026, registering a CAGR of 3.9% from 2019 to 2026.
The global antimalarial drugs market accounted for $711,360 thousand in 2018 and is expected to reach $1,019,396 thousand by 2026, registering a CAGR of 4.6% from 2019 to 2026.
The global drug delivery devices market size accounted for $19,061 million in 2018, and is expected to reach $26,742 million by 2026, registering a CAGR of 4.3% from 2019 to 2026.
The global uveitis treatment market was valued at $478 million in 2018, and is projected to reach $687 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
The global polycystic ovarian syndrome treatment market size was valued at $2,902 million in 2018, and is projected to reach $4,184 million by 2026, registering a CAGR of 4.7% from 2019 to 2026.
The global anti-rheumatics market accounted for $57,229 million in 2018 and is expected to reach $71,934 million by 2026, registering a CAGR of 2.9% from 2019 to 2026.
The global antihypertensive market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2026, registering a CAGR of 3.1% from 2019 to 2026.
The global top 10 cancer drugs market sales was valued at $63,619 million in 2018 and is expected to reach $129,948 million by 2026, registering a CAGR of 9.8% from 2019 to 2026.
Page 1 of 3
There might be something that we haven’t covered in the scope and if it is as per your specific areas of interest, we can anytime customise and incorporate your requirements in the framework of the study and provide you with a customised report based on your exact needs.